UK Treasury Rejects Proposal to Cut VAT on Public EV Charging to 5 Amid Interdepartmental Disagreement Wilson Sonsini Advises Greenhouse on Acquisition of Ezra AI Labs US Stocks Rebound on USIran Peace Hopes Dow Hits Record High SP 500 and Nasdaq Gain AI Reshapes Labor Market BlueCollar Skilled Trades Gain as WhiteCollar Entry Jobs Slow Morgan Stanley Flags Contract Renewal Risks for GDS Holdings Growth Outlook Donald Trump JrBacked Enhanced Games Set for Sunday Debut with Broader Expansion Plans TOST Q1 2026 Earnings Profitability Surprise Drives Modest Stock Uptick ZBIO Q1 2026 Earnings Loss Narrows as EPS Surprises to the Upside ATYR Q1 2026 Earnings Narrower Loss Per Share Beats Expectations Stock Dips on Pipeline Update CBSH Q1 2026 Earnings EPS Surpasses Estimates by 71 Amid Solid Operating Performance Hillman Solutions Corp HLMN Q1 2026 Earnings EPS Misses Estimates as Operational Costs Weigh on Results JKHY Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Uncertainty Bluerock Private Real Estate Fund BPRE Rises 237 as Real Estate Sector Stabilizes Lifezone Metals LZM Surges Over 8 Testing Key Resistance at 534 NovaBay Pharmaceuticals NBY Surges 226 Key Levels to Monitor Bunge Limited BG Rises 13 Key Levels and Sector Strength Hudson Pacific Properties HPP Edges Lower as Office REIT Faces Cautious Investor Sentiment RPC Inc RES Q1 2026 Earnings EPS Surpasses Estimates Amid Revenue Discretion and Share Decline ARM Q1 2026 Earnings EPS Beat Fails to Lift Shares as Market Weighs Headwinds Capri Holdings Q1 2026 Earnings EPS Beat Bolsters Investor Sentiment Despite Revenue Uncertainty Gartner IT Q1 2026 Earnings EPS Smashes Estimates Stock Rises on Strong Execution The9 Limited NCTY Q1 2012 Earnings NarrowerThanExpected Loss Signals Cost Discipline Amid Revenue Uncertainty APAM Q1 2026 Earnings EPS Misses Consensus as Market Headwinds Persist Nvidias Blockbuster Quarter Reveals 200 Billion Edge Computing Opportunity Amid China Market Shift GEVO Q1 2026 Earnings Significant EPS Miss Amid Operational Transition Arbutus Biopharma ABUS Dips 2 Testing Key Support Levels Amid Modest Trading Volume